Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
00:00:02 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 90.56 USD | +1.67% |
|
+4.57% | +6.23% |
| Market Cap | 51.34B 45.91B 42.47B 38.46B 71.98B 4,885B 73.15B 511B 202B 2,555B 193B 189B 8,089B | P/E 2026 * |
35.9x | P/E 2027 * | 27.5x |
|---|---|---|---|---|---|
| Enterprise Value | 47.71B 42.66B 39.47B 35.74B 66.88B 4,539B 67.98B 475B 188B 2,374B 179B 175B 7,517B | EV / Sales 2026 * |
7.06x | EV / Sales 2027 * | 6.21x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Xetra
| EWL | Delayed | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.67% | ||
| 1 week | +4.57% | ||
| Current month | +4.91% | ||
| 1 month | +4.95% | ||
| 3 months | +9.60% | ||
| 6 months | +7.62% | ||
| Current year | +6.23% |
| 1 week | 87.06 |  | 91.05 |
| 1 month | 82.42 | | 91.05 |
| Current year | 74.66 | | 96.29 |
| 1 year | 74.66 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/09/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/09/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.67% | +4.57% | +19.00% | +32.51% | 51.34B | |
| +1.64% | -0.74% | +19.63% | +58.11% | 249B | |
| +1.07% | +1.72% | +4.47% | +20.93% | 162B | |
| -0.15% | +5.84% | -17.36% | +69.40% | 157B | |
| -0.24% | +2.68% | -54.92% | -8.82% | 66.22B | |
| -1.50% | +2.52% | +8.59% | +63.35% | 52.3B | |
| +1.03% | +2.03% | -14.62% | -11.58% | 52.18B | |
| +1.67% | +1.73% | +18.87% | +70.17% | 48.79B | |
| +0.51% | +4.36% | +26.84% | +88.19% | 44.57B | |
| +0.60% | +3.24% | +170.74% | +137.90% | 40.68B | |
| Average | +0.60% | +2.17% | +18.12% | +52.02% | 92.42B | |
| Weighted average by Cap. | +0.70% | +1.46% | +9.72% | +49.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.05B 5.59B 5.06B 9.48B 643B 9.63B 67.31B 26.62B 336B 25.37B 24.83B 1,065B | 7.43B 6.64B 6.15B 5.57B 10.42B 707B 10.59B 73.97B 29.26B 370B 27.89B 27.29B 1,171B |
| Net income | 1.46B 1.3B 1.21B 1.09B 2.04B 139B 2.08B 14.52B 5.74B 72.57B 5.47B 5.36B 230B | 1.88B 1.68B 1.56B 1.41B 2.64B 179B 2.68B 18.73B 7.41B 93.64B 7.06B 6.91B 296B |
| Net Debt | -3.63B -3.25B -3B -2.72B -5.09B -345B -5.17B -36.15B -14.3B -181B -13.63B -13.34B -572B | -5.19B -4.65B -4.3B -3.89B -7.28B -494B -7.4B -51.71B -20.46B -258B -19.5B -19.08B -818B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | $90.56 | +1.67% | 3,326,718 |
| 23/10/26 | $89.07 | -1.13% | 3,101,599 |
| 22/10/26 | $90.09 | +1.91% | 3,054,080 |
| 21/10/26 | $88.40 | +0.12% | 2,717,081 |
| 20/10/26 | $88.29 | +1.23% | 1,795,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
